C-Prio Ltd is a Software and Technology startup specialising in the development and provision of histopathology AI models tailored for drug discovery and personalised medicine. With a strong emphasis on delivering exceptionally high granularity, accuracy, and training efficiency, C-Prio Ltd excels in stratifying patient populations to enhance the safety and efficacy of new therapies based on histopathology digital images. The company has been recognised for its innovative solutions and products, having won several awards that underscore its contributions to the field.

Services include:
- Biopharmaceuticals
- Development of histopathology AI models
- Patient population stratification
- Validation of histopathology workflows

C-Prio Ltd continues to collaborate with three UK NHS hospitals to validate its rAI-colon solution, which aims to streamline histopathology workflows for colorectal biopsies. For more information, please visit c-prio.com.